Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,073,110
-$158,895 QoQ
Shares Held
86,776
-24.8% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#113
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Sep 30, 2024CallValue
$484,250
CallShares
25,000
PutValue
$484,250
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. ARWR ranks #34 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ARWR
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,073,110 | 86,776 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,232,005 | 115,343 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,366,492 | 321,833 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,079,742 | 350,239 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $6,471,726 | 409,603 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $2,931,958 | 230,138 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $5,876,128 | 312,560 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $5,357,935 | 276,610 | Shares | Sole | 2026-03-31 | |
| 2024-09-30 | $484,250 | 25,000 | Call | Sole | 2026-03-31 | |
| 2024-09-30 | $484,250 | 25,000 | Put | Sole | 2026-03-31 | |
| 2024-06-30 | $2,834,313 | 109,054 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $6,382,032 | 223,148 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $1,515,800 | 53,000 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $1,515,800 | 53,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $918,000 | 30,000 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $11,075,884 | 361,957 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $918,000 | 30,000 | Put | Sole | 2026-03-24 | |
| 2023-09-30 | $5,312,817 | 197,723 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $12,726,375 | 356,881 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $8,025,942 | 315,982 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $13,757,181 | 339,181 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $9,858,715 | 298,297 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $6,751,869 | 191,760 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $1,619,660 | 46,000 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $6,710,354 | 145,909 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,723,448 | 267,322 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,571,283 | 217,384 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $17,149,453 | 207,069 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $14,882,283 | 224,435 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,614,104 | 164,396 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,567,346 | 198,963 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,444,595 | 195,522 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,349,723 | 185,948 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||